CRO NACE Rev. 2 46.52 in IE. Official registry identity and a deliberately broad sector benchmark on one indexed company profile.
A deliberately broad indicative range built from comparable companies with stronger filed or size evidence. It is not a company-specific appraisal, market value, asking price, or offer.
Broad benchmark based on comparable companies in this sector — not a company-specific appraisalCreate a free account to see the detailed curve, the factors that influence it, and an indicative five-year outlook.
Free account · private workspace
Each step adds evidence that narrows the range. Public filings are a starting point. Connected accounts, owner context and method review make the valuation more useful for real decisions.
Continue privately and connect your accounting data to make the graph more accurate.
Continue as ownerTrack the buying status below. If the owner opens a process, you can request a conversation and review the details before making an offer.
View buying statusThis broad public range is a starting point based on governed sector or size evidence. Create a free account to refine it with verified company data and build a five-year outlook.
This company is not currently listed for sale on Upswitch.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
RE-CELL TECHNOLOGY SOLUTIONS LIMITED is a CRO NACE Rev. 2 46.52 based in Ireland. The company was founded in 2021, incorporated as a LTD - Private Company Limited by Shares.
RE-CELL TECHNOLOGY SOLUTIONS LIMITED is listed in Irish Companies Registration Office (CRO) under registry number 689209.
Within the Irish NACE 46.52 cluster, public-record data is filed annually via the national company registry.
RE-CELL TECHNOLOGY SOLUTIONS LIMITED's public range is a deliberately broad p10-p90 sector benchmark based on at least 30 comparable companies with stronger filed or size evidence. It is not a company-specific appraisal, midpoint, sale price, offer, or recommendation.
The most recent annual filing covers 2025 (period end 2025-02-28).
If you are researching RE-CELL TECHNOLOGY SOLUTIONS LIMITED, this page combines its official registry identity, sector, legal form, location and incorporation or status facts with a deliberately broad peer benchmark.
RE-CELL TECHNOLOGY SOLUTIONS LIMITED was founded in 2021 and is registered with Irish Companies Registration Office (CRO), incorporated as a LTD - Private Company Limited by Shares.
RE-CELL TECHNOLOGY SOLUTIONS LIMITED is registered under NACE 46.52: CRO NACE Rev. 2 46.52. That places the business within the Irish cluster for this activity.
The most recently filed annual accounts cover fiscal year 2025 (period end 2025-02-28), publicly available via Irish Companies Registration Office (CRO).
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for RE-CELL TECHNOLOGY SOLUTIONS LIMITED may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
